Berstad A, Aadland E, Carlsen E, Myren J, Semb L S, Kruse-Jensen A
Scand J Gastroenterol. 1979;14(7):827-31. doi: 10.3109/00365527909181411.
Fifty-eight patients with endoscopically verified duodenal ulcers were treated with cimetidine, 1 g/day, for 6--10 weeks. The ulcers healed in 52 out of the 54 patients completing the treatment (96.3%). Forty-seven of the patients with healed ulcer were randomly allocated to 1 year of maintenance treatment, 23 patients with cimetidine, 400 mg at night, and 24 patients with placebo tablets. In the cimetidine-treated group 2 out of the 20 patients (10%) completing the trial had recurrence of ulceration, whereas 16 out of the 23 patients (70%) completing the placebo treatment had ulcer recurrence (p less than 0.001). The drug was well tolerated and, except for a marked increase in serum transaminases in three patients, no serious side effects were seen.
58例经内镜证实为十二指肠溃疡的患者接受了西咪替丁治疗,剂量为每日1克,疗程6至10周。54例完成治疗的患者中有52例溃疡愈合(96.3%)。47例溃疡已愈合的患者被随机分配接受为期1年的维持治疗,23例患者服用西咪替丁,每晚400毫克,24例患者服用安慰剂片。在接受西咪替丁治疗的组中,完成试验的20例患者中有2例(10%)溃疡复发,而在完成安慰剂治疗的23例患者中有16例(70%)溃疡复发(p<0.001)。该药物耐受性良好,除3例患者血清转氨酶显著升高外,未观察到严重副作用。